• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7
2
2
2
1

COUNTRY

2
1

PRICE

1
4
7
12

PUBLISHED

0
0
6
12

PRODUCT TYPE

11
1

Cervical Cancer

Cervical cancer is the second most common and the fifth most deadly cancer in women. Approximately 80% of cervical cancers occur in developing countries which makes emerging economies such as China a major target market for pharmaceutical companies in the cervical cancer sector. The following expert reports enable buyers to examine the essential issues: supply and demand, forecasts, drug development and discovery, licensing, SWOT analyses, key industry players and more. This is the place for the inside track on market entry opportunities, growth strategies, buyer solutions and potential industry alliances in the area of cervical cancer drug development. Show Less Read more

PRODUCT TITLE
Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015 Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Cervical Cancer patient population study in a new report ‘Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights...

January 2015
FROM

Global Cervical Cancer Diagnostic Tests Market 2014-2018

About Cervical Cancer Diagnostic Tests Cervical cancer diagnostic tests are used to identify the presence of the precancerous or cancerous lesions in the cervix of a woman. These tests include an initial...

December 2014
FROM
Cervical Cancer Pipeline Highlights - 2015 Cervical Cancer Pipeline Highlights - 2015 - Product Thumbnail Image

Cervical Cancer Pipeline Highlights - 2015

The latest report Cervical Cancer Pipeline Highlights – 2015, provides most up-to-date information on key pipeline molecules in the global Cervical Cancer market. It covers emerging therapies for Cervical...

November 2014
FROM

Advances in Cervical Cancer Management

Cervical cancer is a global health problem and is the third most common cancer in women worldwide. Approximately 85% of the cases occur in women living in developing countries. The majority of invasive...

October 2014

Cervical Cancer Treatment Drugs Markets in China

China's demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's...

June 2014
FROM

Cervical Cancer Drug Market & Pipeline Insight

Cervical cancer is the third and fourth most common cause of cancer incidence and mortality among women across the world. Though there has been a decline in cervical cancer mortality rates in the previous...

June 2014
FROM
Global Cervical Cancer Pipeline Capsule - 2013 Global Cervical Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Cervical Cancer Pipeline Capsule - 2013

Fore Pharma’s latest report ‘Global Cervical Cancer Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global cervical cancer market. It...

April 2013
FROM
Disease and Therapy Review: Cervical Cancer Disease and Therapy Review: Cervical Cancer - Product Thumbnail Image

Disease and Therapy Review: Cervical Cancer

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format These reports are prepared by the senior market...

February 2012
FROM

Cervical Cancer Global Clinical Trials Review, H2, 2011

Cervical Cancer Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Cervical Cancer Global Clinical Trials Review, H2, 2011" provides data on the Cervical Cancer clinical...

August 2011
FROM
2011 Global Markets for External Radiation Therapy 2011 Global Markets for External Radiation Therapy - Product Thumbnail Image

2011 Global Markets for External Radiation Therapy

2011 Global Markets for External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data...

May 2011
FROM
2011 O.U.S. Markets For External Radiation Therapy 2011 O.U.S. Markets For External Radiation Therapy - Product Thumbnail Image

2011 O.U.S. Markets For External Radiation Therapy

2011 O U S Markets For External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data...

May 2011
FROM
2011 U.S. Markets for External Radiation Therapy 2011 U.S. Markets for External Radiation Therapy - Product Thumbnail Image

2011 U.S. Markets for External Radiation Therapy

2011 U S Markets for External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data -...

May 2011
FROM
Loading Indicator

Our Clients

Eli Lilly and Company Roche Diagnostics Ltd. Aviva Plc. Merck & Co., Inc. GlaxoSmithKline PLC CSL Limited